Antidepressants and public health in Iceland. Time series analysis of national data

2.50
Hdl Handle:
http://hdl.handle.net/2336/21873
Title:
Antidepressants and public health in Iceland. Time series analysis of national data
Authors:
Helgason, Tomas; Tomasson, Helgi; Zoega, Tomas
Citation:
Br J Psychiatry. 2004, 184:157-62
Issue Date:
1-Feb-2004
Abstract:
BACKGROUND: Major depressive disorder is the second leading cause of disability-adjusted life-years in developed regions of the world and antidepressants are the third-ranking therapy class worldwide. AIMS: To test the public health impact of the escalating sales of antidepressants. METHOD: Nationwide data from Iceland are used as an example to study the effect of sales of antidepressants on suicide, disability, hospital admissions and out-patient visits. RESULTS: Sales of antidepressants increased from 8.4 daily defined doses per 1000 inhabitants per day in 1975 to 72.7 in 2000, which is a user prevalence of 8.7% for the adult population. Suicide rates fluctuated during 1950-2000 but did not show any definite trend. Rates for out-patient visits increased slightly over the period 1989-2000 and admission rates increased even more. The prevalence of disability due to depressive and anxiety disorders has not decreased over the past 25 years. CONCLUSIONS: The dramatic increase in the sales of antidepressants has not had any marked impact on the selected public health measures. Obviously, better treatment for depressive disorders is still needed in order to reduce the burden caused by them.
Description:
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field
Additional Links:
http://bjp.rcpsych.org/cgi/content/abstract/184/2/157

Full metadata record

DC FieldValue Language
dc.contributor.authorHelgason, Tomas-
dc.contributor.authorTomasson, Helgi-
dc.contributor.authorZoega, Tomas-
dc.date.accessioned2008-03-28T15:20:44Z-
dc.date.available2008-03-28T15:20:44Z-
dc.date.issued2004-02-01-
dc.date.submitted2008-03-28-
dc.identifier.citationBr J Psychiatry. 2004, 184:157-62en
dc.identifier.issn0007-1250-
dc.identifier.pmid14754829-
dc.identifier.urihttp://hdl.handle.net/2336/21873-
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractBACKGROUND: Major depressive disorder is the second leading cause of disability-adjusted life-years in developed regions of the world and antidepressants are the third-ranking therapy class worldwide. AIMS: To test the public health impact of the escalating sales of antidepressants. METHOD: Nationwide data from Iceland are used as an example to study the effect of sales of antidepressants on suicide, disability, hospital admissions and out-patient visits. RESULTS: Sales of antidepressants increased from 8.4 daily defined doses per 1000 inhabitants per day in 1975 to 72.7 in 2000, which is a user prevalence of 8.7% for the adult population. Suicide rates fluctuated during 1950-2000 but did not show any definite trend. Rates for out-patient visits increased slightly over the period 1989-2000 and admission rates increased even more. The prevalence of disability due to depressive and anxiety disorders has not decreased over the past 25 years. CONCLUSIONS: The dramatic increase in the sales of antidepressants has not had any marked impact on the selected public health measures. Obviously, better treatment for depressive disorders is still needed in order to reduce the burden caused by them.en
dc.language.isoenen
dc.relation.urlhttp://bjp.rcpsych.org/cgi/content/abstract/184/2/157en
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAmbulatory Careen
dc.subject.meshAntidepressive Agentsen
dc.subject.meshAntidepressive Agents, Tricyclicen
dc.subject.meshAnxiety Disordersen
dc.subject.meshDepressive Disorderen
dc.subject.meshHospitalizationen
dc.subject.meshHumansen
dc.subject.meshIcelanden
dc.subject.meshPatient Acceptance of Health Careen
dc.subject.meshPublic Healthen
dc.subject.meshSerotonin Uptake Inhibitorsen
dc.subject.meshSuicideen
dc.subject.meshTime Factorsen
dc.titleAntidepressants and public health in Iceland. Time series analysis of national dataen
dc.typeArticleen
dc.identifier.journalBritish journal of psychiatry : the journal of mental scienceen

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.